These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

373 related items for PubMed ID: 1421905

  • 1. Atrial natriuretic peptide in the diagnosis of patent ductus arteriosus.
    Weir FJ, Smith A, Littleton P, Carter N, Hamilton PA.
    Acta Paediatr; 1992 Sep; 81(9):672-5. PubMed ID: 1421905
    [Abstract] [Full Text] [Related]

  • 2. Atrial natriuretic peptide and patent ductus arteriosus in preterm infants.
    Rascher W, Seyberth HW.
    Arch Dis Child; 1987 Nov; 62(11):1165-7. PubMed ID: 2961310
    [Abstract] [Full Text] [Related]

  • 3. N-terminal-pro-brain natriuretic peptide: a guide for early targeted indomethacin therapy for patent ductus arteriosus in preterm Infants.
    Nuntnarumit P, Chongkongkiat P, Khositseth A.
    Acta Paediatr; 2011 Sep; 100(9):1217-21. PubMed ID: 21457304
    [Abstract] [Full Text] [Related]

  • 4. Factors associated with permanent closure of the ductus arteriosus: a role for prolonged indomethacin therapy.
    Quinn D, Cooper B, Clyman RI.
    Pediatrics; 2002 Jul; 110(1 Pt 1):e10. PubMed ID: 12093991
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Cardiovascular biomarkers pro-atrial natriuretic peptide and pro-endothelin-1 to monitor ductus arteriosus evolution in very preterm infants.
    Grass B, Baumann P, Arlettaz R, Fouzas S, Meyer P, Spanaus K, Wellmann S.
    Early Hum Dev; 2014 Jun; 90(6):293-8. PubMed ID: 24661445
    [Abstract] [Full Text] [Related]

  • 7. A comparison of ibuprofen and indomethacin for closure of patent ductus arteriosus.
    Van Overmeire B, Smets K, Lecoutere D, Van de Broek H, Weyler J, Degroote K, Langhendries JP.
    N Engl J Med; 2000 Sep 07; 343(10):674-81. PubMed ID: 10974130
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Prolonged versus short course of indomethacin for the treatment of patent ductus arteriosus in preterm infants.
    Herrera C, Holberton J, Davis P.
    Cochrane Database Syst Rev; 2004 Sep 07; (1):CD003480. PubMed ID: 14974018
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Consequences of delayed surgical closure of patent ductus arteriosus in very premature infants.
    Jaillard S, Larrue B, Rakza T, Magnenant E, Warembourg H, Storme L.
    Ann Thorac Surg; 2006 Jan 07; 81(1):231-4. PubMed ID: 16368371
    [Abstract] [Full Text] [Related]

  • 17. Radiographic and echocardiographic evaluation of newborns treated with indomethacin for patent ductus arteriosus.
    Edwards DK, Higgins CB, Merritt TA, DiSessa TG, Friedman WF.
    AJR Am J Roentgenol; 1978 Dec 07; 131(6):1009-13. PubMed ID: 104563
    [Abstract] [Full Text] [Related]

  • 18. Combined noninvasive assessment of the patent ductus arteriosus in the preterm infant before and after indomethacin treatment.
    Smallhorn JF, Gow R, Olley PM, Freedom RM, Swyer PR, Perlman M, Rowe RD.
    Am J Cardiol; 1984 Dec 01; 54(10):1300-4. PubMed ID: 6507302
    [Abstract] [Full Text] [Related]

  • 19. Indomethacin therapy of patent ductus in preterm infants controlled by plasma levels.
    Lewis IG, Harvey DP, Maxwell GM.
    Aust Paediatr J; 1985 Aug 01; 21(3):181-3. PubMed ID: 4062716
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 19.